Search Results - Subodh Verma

Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome by Subodh Verma, Andrew Kosmopoulos, Deepak L. Bhatt, David Fitchett, Anne Pernille Ofstad, Christoph Wanner, Michaela Mattheus, Bernard Zinman, Patrick R. Lawler, Lawrence A. Leiter

Connect to this object online.

Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial by Ambarish Pandey, Kershaw V. Patel, Matthew W. Segar, Colby Ayers, Jennifer Linge, Olof D. Leinhard, Stefan D. Anker, Javed Butler, Subodh Verma, Parag H. Joshi, Ian J. Neeland

Connect to this object online.

Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved by Andrew J.S. Coats, Javed Butler, Hiroyuki Tsutsui, Wolfram Doehner, Gerasimos Filippatos, João Pedro Ferreira, Michael Böhm, Vijay K. Chopra, Subodh Verma, Matias Nordaby, Tomoko Iwata, Daisuke Nitta, Piotr Ponikowski, Faiez Zannad, Milton Packer, Stefan D. Anker

Connect to this object online.

Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC by Benjamin E. Peterson, M.D, Deepak L. Bhatt, M.D., M.P.H, Ph.Gabriel Steg, M.D, Michael Miller, M.D, Eliot A. Brinton, M.D, Terry A. Jacobson, M.D, Steven B. Ketchum, Rebecca A. Juliano, Ph.D, Lixia Jiao, Ph.D, Ralph T. Doyle, Jr., B.A, Craig Granowitz, M.D., Ph.D, C. Michael Gibson, M.S., M.D, Duane Pinto, M.D, Robert P. Giugliano, M.D., S.M, Matthew J. Budoff, M.D, Jean-Claude Tardif, M.D, Subodh Verma, M.D., Ph.D, Christie M. Ballantyne, M.D

Connect to this object online.